If we treated BCP rats with FTY720 or PRG-1 overexpression, PRG-1 and PRG-1/PP2A binding were enhanced, counteract the effect of Ca2+ increase, enabled dendritic spine density recovery, alleviated bone cancer pain and depression. The gene discussed is PTPA; the disease is bone cancer.